. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public

decreased by 578.68 million baht or 43.91% from the same period last year. This is a result of the decrease in production of cars and motorcycles following the consumer demand. 2. The cost of sales and

Company”) would like to submit the Management Discussion and Analysis for the second quarter ended June 30, 2020 as follows: Construction and servic revernue For the first six-month period ended 30th June

(“the Company”) would like to submit the Management Discussion and Analysis for the third quarter ended September 30, 2020 as follows: Construction and servic revernue For the first nine-month period

Baht 24.07 million, decreased Baht 8.55 million or 26.20% due to the Company continuously generates cash inflow from operations to support repayments of long-term loans during the period which caused a

of New Branches Opened (1) (Branch) 14 8 Number of Branches at Period End (1) (Branch) 102 110 Number of Franchise Branches at Period End (1) (Branch) 127 145 Sales from Restaurant Business During the

sale revenue was not sufficient to support the Company’s expenses which effect to the company’s net loss for this period amount of 137.51 million Baht that represented decrease loss 2.83 million Baht or

Auditors dated April 9, 2015. 12.3 The SEC Office begins the period of time for examining facts and considering the application for approval from the date on which the SEC official has received the required

Comprehensive Income – Consolidated (Million Baht) For -month period ended June , Increase (Decrease) % For 6-month period ended June , Increase (Decrease) % 2020 2019 2020 2019 Revenues from sales and services

million baht or (60.77%) by compared with the net profit at 150.72 million baht same period at last year. The changing over than 20% from the main causes as follows: Summary of important financial